l-Arginine intervention at hyper-acute phase protects the prolonged MRI abnormality in MELAS
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1432-1459
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
l-Arginine intervention at hyper-acute phase protects the prolonged MRI abnormality in MELAS ; day:22 ; month:6 ; year:2016 ; pages:1-3
Journal of neurology ; (22.6.2016), 1-3
- Urheber
-
Kitamura, Miyuki
- Beteiligte Personen und Organisationen
-
Yatsuga, Shuichi
Abe, Toshi
Povalko, Nataliya
Saiki, Reo
Ushijima, Kikumi
Yamashita, Yushiro
Koga, Yasutoshi
SpringerLink (Online service)
- DOI
-
10.1007/s00415-016-8069-4
- URN
-
urn:nbn:de:1111-2016062412358
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:57 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Kitamura, Miyuki
- Yatsuga, Shuichi
- Abe, Toshi
- Povalko, Nataliya
- Saiki, Reo
- Ushijima, Kikumi
- Yamashita, Yushiro
- Koga, Yasutoshi
- SpringerLink (Online service)
Ähnliche Objekte (12)
Therapeutic regimen of l-arginine for MELAS: 9-year, prospective, multicenter, clinical research
L-Arginine in diabetes: clinical and preclinical evidence
Transport of L-Arginine Related Cardiovascular Risk Markers
Correction: L-Arginine in diabetes: clinical and preclinical evidence
L-Arginine supplementation as mitochondrial therapy in diabetic cardiomyopathy
Controlled drug delivery of L-Arginine from a polymer matrix
Cleansing effect of acidic L-arginine on human oral biofilm
Purification and characterization of L-arginine deiminase from Penicillium chrysogenum
Controlled drug delivery of L-Arginine from a polymer matrix
L-arginine Supplementation Ameliorates Chronic Bone Loss in Rheumatoid Arthritis
A novel strategy for l-arginine production in engineered Escherichia coli
Lactobacillus plantarum ameliorates NASH-related inflammation by upregulating l-arginine production
Therapeutic regimen of l-arginine for MELAS: 9-year, prospective, multicenter, clinical research
L-Arginine in diabetes: clinical and preclinical evidence
Transport of L-Arginine Related Cardiovascular Risk Markers
Correction: L-Arginine in diabetes: clinical and preclinical evidence
L-Arginine supplementation as mitochondrial therapy in diabetic cardiomyopathy
Controlled drug delivery of L-Arginine from a polymer matrix
Cleansing effect of acidic L-arginine on human oral biofilm
Purification and characterization of L-arginine deiminase from Penicillium chrysogenum
Controlled drug delivery of L-Arginine from a polymer matrix
L-arginine Supplementation Ameliorates Chronic Bone Loss in Rheumatoid Arthritis
A novel strategy for l-arginine production in engineered Escherichia coli
Lactobacillus plantarum ameliorates NASH-related inflammation by upregulating l-arginine production
Therapeutic regimen of l-arginine for MELAS: 9-year, prospective, multicenter, clinical research
L-Arginine in diabetes: clinical and preclinical evidence
Transport of L-Arginine Related Cardiovascular Risk Markers
Correction: L-Arginine in diabetes: clinical and preclinical evidence
L-Arginine supplementation as mitochondrial therapy in diabetic cardiomyopathy
Controlled drug delivery of L-Arginine from a polymer matrix
Cleansing effect of acidic L-arginine on human oral biofilm
Purification and characterization of L-arginine deiminase from Penicillium chrysogenum
Controlled drug delivery of L-Arginine from a polymer matrix
L-arginine Supplementation Ameliorates Chronic Bone Loss in Rheumatoid Arthritis
A novel strategy for l-arginine production in engineered Escherichia coli